Page 87 - ITPS-8-3

INNOSC Theranostics and
Pharmacological Sciences Activity of green-synthesized nanoparticles

Conflict of interest doi: 10.1007/s00424-024-02905-4

The authors declare that they have no competing interests. 6. Zykov IN. Old antibiotics as alternative treatment options
for urinary tract infections caused by ESBL-, AmpC- and
Author contributions carbapenemase-producing Escherichia coli. Norway: The
Arctic University of Norway. 2020.
Conceptualization: Akamu J. Ewunkem 7. Kuo PY, Lin WH, Tang SF, et al. A longitudinal epidemiology
Formal analysis: Akamu J. Ewunkem, Felicia Simpson, study of fluoroquinolone-nonsusceptible Klebsiella
David Holland, Tatyana Bowers pneumoniae reveals an increasing prevalence of qnrB and
Investigation: Akamu J. Ewunkem, Zahirah J. Williams, qnrS in Taiwan. J Infect Public Health. 2024;17(3):457-463.
Uchenna Iloghalu
Methodology: All authors doi: 10.1016/j.jiph.2024.01.005
Writing–original draft: Akamu J. Ewunkem 8. Al-Khikani FH, Jasim SH, Abedulameeralhusayni A.
Writing–review & editing: Akamu J. Ewunkem, Zahirah Fosfomycin sensitivity among Escherichia coli and gram-
J. Williams, Justice L. Brittany, Lydia Merrills, Bliss positive cocci uropathogen. Indian J Med Specialities.
Daodu 2024;15(2):143-144.
doi: 10.4103/injms.injms_118_23
Ethics approval and consent to participate 9. Epand RM, Walker C, Epand RF, Magarvey NA. Molecular
Not applicable. mechanisms of membrane targeting antibiotics. Biochim
Biophys Acta. 2016;1858(5):980-987.
Consent for publication doi: 10.1016/j.bbamem.2015.10.018
Not applicable. 10. Sabnis A, Edwards AM. Lipopolysaccharide as an
antibiotic target. Biochim Biophys Acta Mol Cell Res.
Availability of data 2023;1870(7):119507.
The data that support the findings of this study are available doi: 10.1016/j.bbamcr.2023.119507
upon request from the corresponding author. 11. Fulke AB, Eranezhath S, Swain GK, Tiwari N, Dora GU.
References Land use land cover structural impact on abundance of
antibiotic resistant Bacillus species in tropical estuary of
1. Peleg AY, Hooper DC. Hospital-acquired infections due India. Reg Stud Mar Sci. 2025;82:104005.
to gram-negative bacteria. N Engl J Med. 2010;362(19): doi: 10.1016/j.rsma.2024.104005
1804-1813.
12. Munita JM, Arias CA. Mechanisms of antibiotic resistance.
doi: 10.1056/NEJMra0904124 In: Virulence Mechanisms of Bacterial Pathogens. United
2. Santangelo L, Netti GS, Torres DD, et al. Peripheral nervous States: Wiley; 2016. p. 481-511.
system manifestations of shiga toxin-producing E. Coli- doi: 10.1128/9781555819286.ch17
induced haemolytic uremic syndrome in children. Ital J
Pediatr. 2021;47:181. 13. Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative
bacteria to current antibacterial agents and approaches to
doi: 10.1186/s13052-021-01133-1 resolve it. Molecules. 2020;25(6):1340.
3. Lung TWF, Charytonowicz D, Beaumont KG, et al. doi: 10.3390/molecules25061340
Klebsiella pneumoniae induces host metabolic stress that
promotes tolerance to pulmonary infection. Cell Metab. 14. Kitaba AA, Bonger ZT, Beyene D, et al. Antimicrobial
2022;34(5):761-774.e.9. resistance trends in clinical Escherichia coli and Klebsiella
pneumoniae in Ethiopia. Afr J Lab Med. 2024;13(1):2268.
doi: 10.1016/j.cmet.2022.03.009
doi: 10.4102/ajlm.v13i1.2268
4. Hyun M, Lee JY, Lim KR, Kim HA. Clinical characteristics
of uncomplicated acute pyelonephritis caused by 15. Pandey N, Cascella M. Beta-lactam antibiotics. In: StatPearls.
Escherichia coli and Klebsiella pneumoniae. Infect Dis Ther. Treasure Island, FL: StatPearls Publishing; 2023
2024;13(3):581-595. 16. Tsai YK, Fung CP, Lin JC, et al. Klebsiella pneumoniae outer
doi: 10.1007/s40121-024-00940-3 membrane porins ompK35 and ompK36 play roles in both
antimicrobial resistance and virulence. Antimicrob Agents
5. Schwaderer AL, Rajadhyaksha E, Canas J, Saxena V, Chemother. 2011;55(4):1485-1493.
Hains DS. Intercalated cell function, kidney innate
immunity, and urinary tract infections. Pflügers Arch. doi: 10.1128/aac.01275-10
2024;476(4):565-578. 17. Salam MA, Al-Amin MY, Salam MT, et al. Antimicrobial

Volume 8 Issue 3 (2025) 81 doi: 10.36922/ITPS025080007